Victory for Vexall against Telkom’s BCX over pharmacy software dominance
The ruling against Telkom’s subsidiary will remain in force for six months
12 February 2020 - 17:08
The Competition Tribunal has ruled in favour of Dis-Chem-backed technology company Vexall to stop Telkom subsidiary Business Connexion (BCX) from abusing its dominant position in the pharmacy software industry.
On Wednesday, the tribunal said BCX is prohibited from selling or offering a licence for its “Unisolv” software on condition that a customer purchase value-added services from BCX. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.